These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15607803)

  • 21. Diversity of NK cell receptor repertoire in adult and neonatal mice.
    Kubota A; Kubota S; Lohwasser S; Mager DL; Takei F
    J Immunol; 1999 Jul; 163(1):212-6. PubMed ID: 10384118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.
    Vivier E; Romagné F
    Immunity; 2007 May; 26(5):549-51. PubMed ID: 17521583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
    Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
    J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
    de Matos CT; Berg L; Michaëlsson J; Felländer-Tsai L; Kärre K; Söderström K
    Immunology; 2007 Oct; 122(2):291-301. PubMed ID: 17521371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
    J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
    Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
    Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
    Eidukaite A; Siaurys A; Tamosiunas V
    Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
    Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
    Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor.
    Masilamani M; Narayanan S; Prieto M; Borrego F; Coligan JE
    Traffic; 2008 Jun; 9(6):1019-34. PubMed ID: 18363778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cell-mediated recognition of human trophoblast.
    Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
    Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
    Gross C; Hansch D; Gastpar R; Multhoff G
    Biol Chem; 2003 Feb; 384(2):267-79. PubMed ID: 12675520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells.
    Tanaka J; Iwao N; Toubai T; Tsutsumi Y; Miura Y; Kato N; Shigematsu A; Yamane M; Ota S; Kondo T; Kobayashi T; Takeda H; Kobayashi M; Asaka M; Imamura M
    Leukemia; 2005 Mar; 19(3):486-9. PubMed ID: 15618959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.